Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-07-16FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic levothyroxine sodium product from Aurobindo Pharma Limited via an Original Application (ANDA), authorizing its use as…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Energy Metabolism in Thyroidectomized Patients [Phase 2]
Phase 2 clinical trial update on energy metabolism in thyroidectomized patients. The study has completed and posted results (June 14, 2024) …
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
This clinical trial is evaluating the efficacy and safety of catheter ablation for atrial fibrillation in patients stabilized on thyroid hor…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants [Phase 2]
Phase 2 study comparing Armour Thyroid with levothyroxine in people with prior hypothyroidism, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Pharmacist Role in Thyroid Disorders [NA]
This completed clinical trial evaluates the role of pharmacists in managing thyroid disorders, including hypothyroidism and hyperthyroidism.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism
This ClinicalTrials.gov entry describes a study investigating insulin resistance in relation to hyperthyroidism and hypothyroidism, sponsore…
-
FDA approval · 2024-02-20FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, resulting in changes to the product's labeling.
-
FDA approval · 2024-02-06FDA Approved: LIOTHYRONINE SODIUM — Original Application (Biocon Pharma Inc.)
FDA approved Liothyronine sodium (Biocon Pharma Inc.) under an Original Application (ANDA) as a generic treatment for hypothyroidism.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism [Phase 2]
Phase 2 clinical trial investigating the effect of vitamin C supplementation in patients with primary hypothyroidism.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients [Phase 3]
A Phase 3 clinical trial evaluating TSH suppression during radiotherapy to prevent iatrogenic hypothyroidism in pediatric cancer patients is…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism [Phase 4]
A Phase 4 clinical trial assessing the impact of increasing levothyroxine dose during Ramadan in UAE patients with hypothyroidism has been c…
-
FDA approval · 2023-11-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium by Alvogen, Inc., updating the regulatory status for this product under…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance [Phase 4]
Phase 4 trial investigating the effect of lifestyle modification and metformin on hypothyroidism with insulin resistance.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women [Phase 3]
Phase 3 clinical trial of thyroxine therapy in hypothyroid women with recurrent pregnancy loss has been completed.
-
FDA approval · 2023-08-08FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for levothyroxine sodium from Teva Pharmaceuticals under ANDA 207588. This represents a routine …
-
FDA approval · 2023-07-21FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Levothyroxine Sodium, a generic product used to treat hypothyroidism and re…
-
FDA label_change · 2023-07-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA supplemental application filed for Levothyroxine Sodium by Mylan Pharmaceuticals Inc., an approved generic, likely to address labeling c…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating combined levothyroxine and liothyronine therapy in hypothyroid patients after thyroidectomy has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients [Phase 4]
Phase 4 clinical trial evaluating liquid stable levothyroxine in pediatric patients with hypothyroidism and Trisomy 21 has been terminated w…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding [Phase 4]
Phase 4 trial update evaluating different levothyroxine formulations in hypothyroid patients receiving enteral feeding; study terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women [Phase 2]
A Phase 2 trial evaluating the effect of acupuncture combined with a low-calorie diet on primary hypothyroidism and menstrual irregularities…
-
FDA approval · 2023-03-24FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original ANDA for Levothyroxine Sodium from Zydus Pharmaceuticals USA Inc., expanding access to a generic thyroid hormone r…
-
FDA approval · 2023-01-18FDA Approved: LEVOTHYROXINE SODIUM — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original application for levothyroxine sodium from XLCare Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism [Phase 4]
Phase 4 trial evaluating how L-thyroxine replacement affects serum lipids and atherosclerosis in hypothyroidism.
-
FDA approval · 2022-12-21FDA Approved: LEVOTHYROXINE SODIUM — Original Application (NorthStar RxLLC)
FDA approved the original application for levothyroxine sodium as a generic thyroid hormone replacement product from NorthStar RxLLC.